Open | 1.15 |
Previous Close | 1.1 |
Day Range | 1.11 - 1.15 |
52-Week Range | 0.85 - 4.40 |
All-Time High | 5,000.00 |
Avg. Volume (50-day) | 29,499.3 |
EPS (TTM) | -2.03 |
Next Earnings Date | - |
Last Earnings Date | - |
Forward Annual Dividend (Yield) | - |
Trailing Annual Dividend (Yield) | - |
Options | No |
P/E Ratio | -0.16 |
PEG Ratio | - |
Price to Book | -2.00 |
Price to Cash Flow | - |
Price to Free Cash Flow | - |
Total Sales (TTM) | - |
Revenue per Share (TTM) | - |
Shares Outstanding | 12.145 M |
Share Float (%) | 12.10 M |
% Held by Institutions | 2.66 |
Dividends Per Share (TTM) | - |
Ex-Dividend Date | - |
+/- EMA(20) | 1.2 (-7.46%) |
+/- SMA(50) | 1.13 (-1.73%) |
+/- SMA(200) | 2.23 (-50.20%) |
5-Day Perf. | -14.93% |
1-Month Perf. | +27.64% |
3-Month Perf. | -8.22% |
6-Month Perf. | -61.17% |
YTD Perf. | -8.98% |
1-Year Perf. | -26.46% |
RSI(14) | 45.91 |
ATR(14) | 0.12 |
ADX(14) | 29.79 |
Beta (5Y) | 0.45 |
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. The company was founded on October 7, 2004 and is headquartered in Boston, MA.
AKTX has triggered the following predefined scans:
No Recent Scan Appearances |
As a StockCharts Member, you can create your own unique alerts with the technical criteria that matters most to you. Stay ahead of important moves and never miss a thing in the markets.
As a StockCharts Member, you can save the charts you're watching to your own account with ChartLists. Accessible from any device, you can organize, review and analyze your charts on-the-go, anytime, anywhere.